Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant trend » significant threat (Expand Search), significant threats (Expand Search), significant burden (Expand Search)
trend decrease » teer decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant trend » significant threat (Expand Search), significant threats (Expand Search), significant burden (Expand Search)
trend decrease » teer decrease (Expand Search)
-
2981
-
2982
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2983
-
2984
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2985
-
2986
-
2987
-
2988
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2989
-
2990
-
2991
-
2992
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2993
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2994
-
2995
-
2996
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2997
-
2998
-
2999
-
3000